Moleculin Biotech posts investor presentation; no material new information

Moleculin Biotech, Inc.

Presentation furnished under Item 7.01 on March 19, 2026.
No financial results, operational updates, or guidance provided in the filing.
Presentation is not incorporated by reference into SEC filings.
Exhibit 99.1 is an image exhibit with no extractable text or data.

item 7.01 item 9.01

Moleculin Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-008951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.